cvs-20220630000006480312/312022Q2falsehttp://fasb.org/us-gaap/2022#ProductMemberhttp://fasb.org/us-gaap/2022#ProductMemberhttp://fasb.org/us-gaap/2022#ProductMemberhttp://fasb.org/us-gaap/2022#ProductMemberhttp://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationshttp://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations00000648032022-01-012022-06-3000000648032022-07-27xbrli:shares0000064803us-gaap:ProductMember2022-04-012022-06-30iso4217:USD0000064803us-gaap:ProductMember2021-04-012021-06-300000064803us-gaap:ProductMember2022-01-012022-06-300000064803us-gaap:ProductMember2021-01-012021-06-3000000648032022-04-012022-06-3000000648032021-04-012021-06-3000000648032021-01-012021-06-300000064803us-gaap:ServiceMember2022-04-012022-06-300000064803us-gaap:ServiceMember2021-04-012021-06-300000064803us-gaap:ServiceMember2022-01-012022-06-300000064803us-gaap:ServiceMember2021-01-012021-06-30iso4217:USDxbrli:shares00000648032022-06-3000000648032021-12-3100000648032020-12-3100000648032021-06-300000064803us-gaap:CommonStockMember2021-12-310000064803us-gaap:TreasuryStockCommonMember2021-12-310000064803us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2021-12-310000064803us-gaap:RetainedEarningsMember2021-12-310000064803us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000064803us-gaap:ParentMember2021-12-310000064803us-gaap:NoncontrollingInterestMember2021-12-310000064803us-gaap:RetainedEarningsMember2022-01-012022-03-310000064803us-gaap:ParentMember2022-01-012022-03-310000064803us-gaap:NoncontrollingInterestMember2022-01-012022-03-3100000648032022-01-012022-03-310000064803us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000064803us-gaap:CommonStockMember2022-01-012022-03-310000064803us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-01-012022-03-310000064803us-gaap:TreasuryStockCommonMember2022-01-012022-03-310000064803us-gaap:CommonStockMember2022-03-310000064803us-gaap:TreasuryStockCommonMember2022-03-310000064803us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-03-310000064803us-gaap:RetainedEarningsMember2022-03-310000064803us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000064803us-gaap:ParentMember2022-03-310000064803us-gaap:NoncontrollingInterestMember2022-03-3100000648032022-03-310000064803us-gaap:RetainedEarningsMember2022-04-012022-06-300000064803us-gaap:ParentMember2022-04-012022-06-300000064803us-gaap:NoncontrollingInterestMember2022-04-012022-06-300000064803us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300000064803us-gaap:CommonStockMember2022-04-012022-06-300000064803us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-04-012022-06-300000064803us-gaap:TreasuryStockCommonMember2022-04-012022-06-300000064803us-gaap:CommonStockMember2022-06-300000064803us-gaap:TreasuryStockCommonMember2022-06-300000064803us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-06-300000064803us-gaap:RetainedEarningsMember2022-06-300000064803us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000064803us-gaap:ParentMember2022-06-300000064803us-gaap:NoncontrollingInterestMember2022-06-300000064803us-gaap:CommonStockMember2020-12-310000064803us-gaap:TreasuryStockCommonMember2020-12-310000064803us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2020-12-310000064803us-gaap:RetainedEarningsMember2020-12-310000064803us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000064803us-gaap:ParentMember2020-12-310000064803us-gaap:NoncontrollingInterestMember2020-12-310000064803us-gaap:RetainedEarningsMember2021-01-012021-03-310000064803us-gaap:ParentMember2021-01-012021-03-310000064803us-gaap:NoncontrollingInterestMember2021-01-012021-03-3100000648032021-01-012021-03-310000064803us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310000064803us-gaap:CommonStockMember2021-01-012021-03-310000064803us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2021-01-012021-03-310000064803us-gaap:TreasuryStockCommonMember2021-01-012021-03-310000064803us-gaap:CommonStockMember2021-03-310000064803us-gaap:TreasuryStockCommonMember2021-03-310000064803us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2021-03-310000064803us-gaap:RetainedEarningsMember2021-03-310000064803us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310000064803us-gaap:ParentMember2021-03-310000064803us-gaap:NoncontrollingInterestMember2021-03-3100000648032021-03-310000064803us-gaap:RetainedEarningsMember2021-04-012021-06-300000064803us-gaap:ParentMember2021-04-012021-06-300000064803us-gaap:NoncontrollingInterestMember2021-04-012021-06-300000064803us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300000064803us-gaap:CommonStockMember2021-04-012021-06-300000064803us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2021-04-012021-06-300000064803us-gaap:TreasuryStockCommonMember2021-04-012021-06-300000064803us-gaap:CommonStockMember2021-06-300000064803us-gaap:TreasuryStockCommonMember2021-06-300000064803us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2021-06-300000064803us-gaap:RetainedEarningsMember2021-06-300000064803us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300000064803us-gaap:ParentMember2021-06-300000064803us-gaap:NoncontrollingInterestMember2021-06-300000064803cvs:RetailLongTermCareSegmentMember2022-06-30cvs:storecvs:cliniccvs:peoplecvs:patient0000064803cvs:HealthCareBenefitsSegmentMember2022-06-30cvs:Segment0000064803cvs:HealthCareBenefitsSegmentMember2022-01-012022-06-30cvs:state0000064803srt:ScenarioForecastMembercvs:HealthCareBenefitsSegmentMember2023-01-012023-01-310000064803cvs:PharmacyRevenueMemberus-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2022-04-012022-06-300000064803cvs:PharmacyRevenueMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2022-04-012022-06-300000064803cvs:RetailLongTermCareSegmentMembercvs:PharmacyRevenueMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300000064803us-gaap:CorporateNonSegmentMembercvs:PharmacyRevenueMember2022-04-012022-06-300000064803us-gaap:IntersegmentEliminationMembercvs:PharmacyRevenueMember2022-04-012022-06-300000064803cvs:PharmacyRevenueMember2022-04-012022-06-300000064803us-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMembercvs:FrontStoreRevenueMember2022-04-012022-06-300000064803us-gaap:OperatingSegmentsMembercvs:FrontStoreRevenueMembercvs:PharmacyServicesSegmentMember2022-04-012022-06-300000064803cvs:RetailLongTermCareSegmentMemberus-gaap:OperatingSegmentsMembercvs:FrontStoreRevenueMember2022-04-012022-06-300000064803us-gaap:CorporateNonSegmentMembercvs:FrontStoreRevenueMember2022-04-012022-06-300000064803us-gaap:IntersegmentEliminationMembercvs:FrontStoreRevenueMember2022-04-012022-06-300000064803cvs:FrontStoreRevenueMember2022-04-012022-06-300000064803cvs:PremiumsMemberus-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2022-04-012022-06-300000064803cvs:PremiumsMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2022-04-012022-06-300000064803cvs:RetailLongTermCareSegmentMembercvs:PremiumsMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300000064803us-gaap:CorporateNonSegmentMembercvs:PremiumsMember2022-04-012022-06-300000064803us-gaap:IntersegmentEliminationMembercvs:PremiumsMember2022-04-012022-06-300000064803cvs:PremiumsMember2022-04-012022-06-300000064803us-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2022-04-012022-06-300000064803us-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2022-04-012022-06-300000064803cvs:RetailLongTermCareSegmentMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300000064803us-gaap:CorporateNonSegmentMember2022-04-012022-06-300000064803us-gaap:IntersegmentEliminationMember2022-04-012022-06-300000064803us-gaap:ProductAndServiceOtherMemberus-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2022-04-012022-06-300000064803us-gaap:ProductAndServiceOtherMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2022-04-012022-06-300000064803cvs:RetailLongTermCareSegmentMemberus-gaap:ProductAndServiceOtherMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300000064803us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2022-04-012022-06-300000064803us-gaap:IntersegmentEliminationMemberus-gaap:ProductAndServiceOtherMember2022-04-012022-06-300000064803us-gaap:ProductAndServiceOtherMember2022-04-012022-06-300000064803us-gaap:SalesChannelThroughIntermediaryMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2022-04-012022-06-300000064803us-gaap:OperatingSegmentsMemberus-gaap:SalesChannelDirectlyToConsumerMembercvs:PharmacyServicesSegmentMember2022-04-012022-06-300000064803us-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMembercvs:SalesChannelOtherMember2022-04-012022-06-300000064803cvs:PharmacyRevenueMemberus-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2021-04-012021-06-300000064803cvs:PharmacyRevenueMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2021-04-012021-06-300000064803cvs:RetailLongTermCareSegmentMembercvs:PharmacyRevenueMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300000064803us-gaap:CorporateNonSegmentMembercvs:PharmacyRevenueMember2021-04-012021-06-300000064803us-gaap:IntersegmentEliminationMembercvs:PharmacyRevenueMember2021-04-012021-06-300000064803cvs:PharmacyRevenueMember2021-04-012021-06-300000064803us-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMembercvs:FrontStoreRevenueMember2021-04-012021-06-300000064803us-gaap:OperatingSegmentsMembercvs:FrontStoreRevenueMembercvs:PharmacyServicesSegmentMember2021-04-012021-06-300000064803cvs:RetailLongTermCareSegmentMemberus-gaap:OperatingSegmentsMembercvs:FrontStoreRevenueMember2021-04-012021-06-300000064803us-gaap:CorporateNonSegmentMembercvs:FrontStoreRevenueMember2021-04-012021-06-300000064803us-gaap:IntersegmentEliminationMembercvs:FrontStoreRevenueMember2021-04-012021-06-300000064803cvs:FrontStoreRevenueMember2021-04-012021-06-300000064803cvs:PremiumsMemberus-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2021-04-012021-06-300000064803cvs:PremiumsMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2021-04-012021-06-300000064803cvs:RetailLongTermCareSegmentMembercvs:PremiumsMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300000064803us-gaap:CorporateNonSegmentMembercvs:PremiumsMember2021-04-012021-06-300000064803us-gaap:IntersegmentEliminationMembercvs:PremiumsMember2021-04-012021-06-300000064803cvs:PremiumsMember2021-04-012021-06-300000064803us-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2021-04-012021-06-300000064803us-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2021-04-012021-06-300000064803cvs:RetailLongTermCareSegmentMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300000064803us-gaap:CorporateNonSegmentMember2021-04-012021-06-300000064803us-gaap:IntersegmentEliminationMember2021-04-012021-06-300000064803us-gaap:ProductAndServiceOtherMemberus-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2021-04-012021-06-300000064803us-gaap:ProductAndServiceOtherMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2021-04-012021-06-300000064803cvs:RetailLongTermCareSegmentMemberus-gaap:ProductAndServiceOtherMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300000064803us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2021-04-012021-06-300000064803us-gaap:IntersegmentEliminationMemberus-gaap:ProductAndServiceOtherMember2021-04-012021-06-300000064803us-gaap:ProductAndServiceOtherMember2021-04-012021-06-300000064803us-gaap:SalesChannelThroughIntermediaryMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2021-04-012021-06-300000064803us-gaap:OperatingSegmentsMemberus-gaap:SalesChannelDirectlyToConsumerMembercvs:PharmacyServicesSegmentMember2021-04-012021-06-300000064803us-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMembercvs:SalesChannelOtherMember2021-04-012021-06-300000064803cvs:PharmacyRevenueMemberus-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2022-01-012022-06-300000064803cvs:PharmacyRevenueMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2022-01-012022-06-300000064803cvs:RetailLongTermCareSegmentMembercvs:PharmacyRevenueMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300000064803us-gaap:CorporateNonSegmentMembercvs:PharmacyRevenueMember2022-01-012022-06-300000064803us-gaap:IntersegmentEliminationMembercvs:PharmacyRevenueMember2022-01-012022-06-300000064803cvs:PharmacyRevenueMember2022-01-012022-06-300000064803us-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMembercvs:FrontStoreRevenueMember2022-01-012022-06-300000064803us-gaap:OperatingSegmentsMembercvs:FrontStoreRevenueMembercvs:PharmacyServicesSegmentMember2022-01-012022-06-300000064803cvs:RetailLongTermCareSegmentMemberus-gaap:OperatingSegmentsMembercvs:FrontStoreRevenueMember2022-01-012022-06-300000064803us-gaap:CorporateNonSegmentMembercvs:FrontStoreRevenueMember2022-01-012022-06-300000064803us-gaap:IntersegmentEliminationMembercvs:FrontStoreRevenueMember2022-01-012022-06-300000064803cvs:FrontStoreRevenueMember2022-01-012022-06-300000064803cvs:PremiumsMemberus-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2022-01-012022-06-300000064803cvs:PremiumsMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2022-01-012022-06-300000064803cvs:RetailLongTermCareSegmentMembercvs:PremiumsMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300000064803us-gaap:CorporateNonSegmentMembercvs:PremiumsMember2022-01-012022-06-300000064803us-gaap:IntersegmentEliminationMembercvs:PremiumsMember2022-01-012022-06-300000064803cvs:PremiumsMember2022-01-012022-06-300000064803us-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2022-01-012022-06-300000064803us-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2022-01-012022-06-300000064803cvs:RetailLongTermCareSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300000064803us-gaap:CorporateNonSegmentMember2022-01-012022-06-300000064803us-gaap:IntersegmentEliminationMember2022-01-012022-06-300000064803us-gaap:ProductAndServiceOtherMemberus-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2022-01-012022-06-300000064803us-gaap:ProductAndServiceOtherMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2022-01-012022-06-300000064803cvs:RetailLongTermCareSegmentMemberus-gaap:ProductAndServiceOtherMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300000064803us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2022-01-012022-06-300000064803us-gaap:IntersegmentEliminationMemberus-gaap:ProductAndServiceOtherMember2022-01-012022-06-300000064803us-gaap:ProductAndServiceOtherMember2022-01-012022-06-300000064803us-gaap:SalesChannelThroughIntermediaryMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2022-01-012022-06-300000064803us-gaap:OperatingSegmentsMemberus-gaap:SalesChannelDirectlyToConsumerMembercvs:PharmacyServicesSegmentMember2022-01-012022-06-300000064803us-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMembercvs:SalesChannelOtherMember2022-01-012022-06-300000064803cvs:PharmacyRevenueMemberus-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2021-01-012021-06-300000064803cvs:PharmacyRevenueMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2021-01-012021-06-300000064803cvs:RetailLongTermCareSegmentMembercvs:PharmacyRevenueMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300000064803us-gaap:CorporateNonSegmentMembercvs:PharmacyRevenueMember2021-01-012021-06-300000064803us-gaap:IntersegmentEliminationMembercvs:PharmacyRevenueMember2021-01-012021-06-300000064803cvs:PharmacyRevenueMember2021-01-012021-06-300000064803us-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMembercvs:FrontStoreRevenueMember2021-01-012021-06-300000064803us-gaap:OperatingSegmentsMembercvs:FrontStoreRevenueMembercvs:PharmacyServicesSegmentMember2021-01-012021-06-300000064803cvs:RetailLongTermCareSegmentMemberus-gaap:OperatingSegmentsMembercvs:FrontStoreRevenueMember2021-01-012021-06-300000064803us-gaap:CorporateNonSegmentMembercvs:FrontStoreRevenueMember2021-01-012021-06-300000064803us-gaap:IntersegmentEliminationMembercvs:FrontStoreRevenueMember2021-01-012021-06-300000064803cvs:FrontStoreRevenueMember2021-01-012021-06-300000064803cvs:PremiumsMemberus-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2021-01-012021-06-300000064803cvs:PremiumsMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2021-01-012021-06-300000064803cvs:RetailLongTermCareSegmentMembercvs:PremiumsMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300000064803us-gaap:CorporateNonSegmentMembercvs:PremiumsMember2021-01-012021-06-300000064803us-gaap:IntersegmentEliminationMembercvs:PremiumsMember2021-01-012021-06-300000064803cvs:PremiumsMember2021-01-012021-06-300000064803us-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2021-01-012021-06-300000064803us-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2021-01-012021-06-300000064803cvs:RetailLongTermCareSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300000064803us-gaap:CorporateNonSegmentMember2021-01-012021-06-300000064803us-gaap:IntersegmentEliminationMember2021-01-012021-06-300000064803us-gaap:ProductAndServiceOtherMemberus-gaap:OperatingSegmentsMembercvs:HealthCareBenefitsSegmentMember2021-01-012021-06-300000064803us-gaap:ProductAndServiceOtherMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2021-01-012021-06-300000064803cvs:RetailLongTermCareSegmentMemberus-gaap:ProductAndServiceOtherMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300000064803us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2021-01-012021-06-300000064803us-gaap:IntersegmentEliminationMemberus-gaap:ProductAndServiceOtherMember2021-01-012021-06-300000064803us-gaap:ProductAndServiceOtherMember2021-01-012021-06-300000064803us-gaap:SalesChannelThroughIntermediaryMemberus-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMember2021-01-012021-06-300000064803us-gaap:OperatingSegmentsMemberus-gaap:SalesChannelDirectlyToConsumerMembercvs:PharmacyServicesSegmentMember2021-01-012021-06-300000064803us-gaap:OperatingSegmentsMembercvs:PharmacyServicesSegmentMembercvs:SalesChannelOtherMember2021-01-012021-06-300000064803cvs:HeartlandHealthcareServicesMember2022-06-300000064803us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercvs:PayflexMembercvs:HealthCareBenefitsSegmentMember2022-06-012022-06-010000064803us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercvs:PayflexMembercvs:HealthCareBenefitsSegmentMember2022-04-012022-06-300000064803us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercvs:PayflexMembercvs:HealthCareBenefitsSegmentMember2022-01-012022-06-300000064803cvs:ThailandBusinessMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercvs:HealthCareBenefitsSegmentMember2022-03-31cvs:member0000064803cvs:ThailandBusinessMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercvs:HealthCareBenefitsSegmentMember2022-01-012022-03-310000064803cvs:ThailandBusinessMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercvs:HealthCareBenefitsSegmentMember2022-01-012022-06-300000064803us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercvs:InternationalHealthCareRenewalRightsMember2022-05-310000064803cvs:DebtAndEquitySecuritiesAvailableForSaleMember2022-06-300000064803cvs:DebtAndEquitySecuritiesAvailableForSaleMember2021-12-310000064803cvs:MortgageLoansMember2022-06-300000064803cvs:MortgageLoansMember2021-12-310000064803us-gaap:OtherInvestmentsMember2022-06-300000064803us-gaap:OtherInvestmentsMember2021-12-310000064803us-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-06-300000064803us-gaap:USStatesAndPoliticalSubdivisionsMember2022-06-300000064803us-gaap:DomesticCorporateDebtSecuritiesMember2022-06-300000064803us-gaap:ForeignCorporateDebtSecuritiesMember2022-06-300000064803us-gaap:ResidentialMortgageBackedSecuritiesMember2022-06-300000064803us-gaap:CommercialMortgageBackedSecuritiesMember2022-06-300000064803cvs:OtherAssetBackedSecuritiesMember2022-06-300000064803us-gaap:RedeemablePreferredStockMember2022-06-300000064803us-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-310000064803us-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310000064803us-gaap:DomesticCorporateDebtSecuritiesMember2021-12-310000064803us-gaap:ForeignCorporateDebtSecuritiesMember2021-12-310000064803us-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-310000064803us-gaap:CommercialMortgageBackedSecuritiesMember2021-12-310000064803cvs:OtherAssetBackedSecuritiesMember2021-12-310000064803us-gaap:RedeemablePreferredStockMember2021-12-310000064803cvs:SupportingExperienceRatedProductsMember2022-06-300000064803cvs:SupportingExperienceRatedProductsMember2021-12-31cvs:security0000064803cvs:SupportingRemainingProductsMember2022-06-300000064803cvs:SupportingExperienceRatedProductsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-06-300000064803cvs:SupportingRemainingProductsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-06-300000064803cvs:SupportingExperienceRatedProductsMemberus-gaap:CommercialMortgageBackedSecuritiesMember2022-06-300000064803us-gaap:CommercialMortgageBackedSecuritiesMembercvs:SupportingRemainingProductsMember2022-06-300000064803cvs:SupportingExperienceRatedProductsMembercvs:OtherAssetBackedSecuritiesMember2022-06-300000064803cvs:SupportingRemainingProductsMembercvs:OtherAssetBackedSecuritiesMember2022-06-300000064803us-gaap:CommercialRealEstateMember2022-04-012022-06-300000064803us-gaap:CommercialRealEstateMember2021-04-012021-06-300000064803us-gaap:CommercialRealEstateMember2022-01-012022-06-300000064803us-gaap:CommercialRealEstateMember2021-01-012021-06-300000064803us-gaap:CommercialRealEstateMembercvs:Category1Membercvs:YearOfOriginationPeriodOneMember2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodTwoMembercvs:Category1Member2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:Category1Membercvs:YearOfOriginationPeriodThreeMember2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodFourMembercvs:Category1Member2022-06-300000064803cvs:YearOfOriginationPeriodFiveMemberus-gaap:CommercialRealEstateMembercvs:Category1Member2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPriorToPeriodFiveMembercvs:Category1Member2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:Category1Member2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:Category2To4Membercvs:YearOfOriginationPeriodOneMember2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodTwoMembercvs:Category2To4Member2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:Category2To4Membercvs:YearOfOriginationPeriodThreeMember2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:Category2To4Membercvs:YearOfOriginationPeriodFourMember2022-06-300000064803cvs:YearOfOriginationPeriodFiveMemberus-gaap:CommercialRealEstateMembercvs:Category2To4Member2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:Category2To4Membercvs:YearOfOriginationPriorToPeriodFiveMember2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:Category2To4Member2022-06-300000064803cvs:Categories5and6Memberus-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodOneMember2022-06-300000064803cvs:Categories5and6Memberus-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodTwoMember2022-06-300000064803cvs:Categories5and6Memberus-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodThreeMember2022-06-300000064803cvs:Categories5and6Memberus-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodFourMember2022-06-300000064803cvs:Categories5and6Membercvs:YearOfOriginationPeriodFiveMemberus-gaap:CommercialRealEstateMember2022-06-300000064803cvs:Categories5and6Memberus-gaap:CommercialRealEstateMembercvs:YearOfOriginationPriorToPeriodFiveMember2022-06-300000064803cvs:Categories5and6Memberus-gaap:CommercialRealEstateMember2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodOneMembercvs:Category7Member2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodTwoMembercvs:Category7Member2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:Category7Membercvs:YearOfOriginationPeriodThreeMember2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodFourMembercvs:Category7Member2022-06-300000064803cvs:YearOfOriginationPeriodFiveMemberus-gaap:CommercialRealEstateMembercvs:Category7Member2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPriorToPeriodFiveMembercvs:Category7Member2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:Category7Member2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodOneMember2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodTwoMember2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodThreeMember2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodFourMember2022-06-300000064803cvs:YearOfOriginationPeriodFiveMemberus-gaap:CommercialRealEstateMember2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPriorToPeriodFiveMember2022-06-300000064803us-gaap:CommercialRealEstateMember2022-06-300000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodTwoMembercvs:Category1Member2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:Category1Membercvs:YearOfOriginationPeriodThreeMember2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodFourMembercvs:Category1Member2021-12-310000064803cvs:YearOfOriginationPeriodFiveMemberus-gaap:CommercialRealEstateMembercvs:Category1Member2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPriorToPeriodFiveMembercvs:Category1Member2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:Category1Member2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodTwoMembercvs:Category2To4Member2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:Category2To4Membercvs:YearOfOriginationPeriodThreeMember2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:Category2To4Membercvs:YearOfOriginationPeriodFourMember2021-12-310000064803cvs:YearOfOriginationPeriodFiveMemberus-gaap:CommercialRealEstateMembercvs:Category2To4Member2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:Category2To4Membercvs:YearOfOriginationPriorToPeriodFiveMember2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:Category2To4Member2021-12-310000064803cvs:Categories5and6Memberus-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodTwoMember2021-12-310000064803cvs:Categories5and6Memberus-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodThreeMember2021-12-310000064803cvs:Categories5and6Memberus-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodFourMember2021-12-310000064803cvs:Categories5and6Membercvs:YearOfOriginationPeriodFiveMemberus-gaap:CommercialRealEstateMember2021-12-310000064803cvs:Categories5and6Memberus-gaap:CommercialRealEstateMembercvs:YearOfOriginationPriorToPeriodFiveMember2021-12-310000064803cvs:Categories5and6Memberus-gaap:CommercialRealEstateMember2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodTwoMembercvs:Category7Member2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:Category7Membercvs:YearOfOriginationPeriodThreeMember2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodFourMembercvs:Category7Member2021-12-310000064803cvs:YearOfOriginationPeriodFiveMemberus-gaap:CommercialRealEstateMembercvs:Category7Member2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPriorToPeriodFiveMembercvs:Category7Member2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:Category7Member2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodTwoMember2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodThreeMember2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPeriodFourMember2021-12-310000064803cvs:YearOfOriginationPeriodFiveMemberus-gaap:CommercialRealEstateMember2021-12-310000064803us-gaap:CommercialRealEstateMembercvs:YearOfOriginationPriorToPeriodFiveMember2021-12-310000064803us-gaap:CommercialRealEstateMember2021-12-310000064803us-gaap:DebtSecuritiesMember2022-04-012022-06-300000064803us-gaap:DebtSecuritiesMember2021-04-012021-06-300000064803us-gaap:DebtSecuritiesMember2022-01-012022-06-300000064803us-gaap:DebtSecuritiesMember2021-01-012021-06-300000064803cvs:MortgageLoansMember2022-04-012022-06-300000064803cvs:MortgageLoansMember2021-04-012021-06-300000064803cvs:MortgageLoansMember2022-01-012022-06-300000064803cvs:MortgageLoansMember2021-01-012021-06-300000064803us-gaap:OtherInvestmentsMember2022-04-012022-06-300000064803us-gaap:OtherInvestmentsMember2021-04-012021-06-300000064803us-gaap:OtherInvestmentsMember2022-01-012022-06-300000064803us-gaap:OtherInvestmentsMember2021-01-012021-06-300000064803cvs:SupportingExperienceRatedProductsMember2022-04-012022-06-300000064803cvs:SupportingExperienceRatedProductsMember2022-01-012022-06-300000064803cvs:SupportingExperienceRatedProductsMember2021-04-012021-06-300000064803cvs:SupportingExperienceRatedProductsMember2021-01-012021-06-300000064803us-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-06-300000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel1Member2022-06-300000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DomesticCorporateDebtSecuritiesMember2022-06-300000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DomesticCorporateDebtSecuritiesMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DomesticCorporateDebtSecuritiesMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DomesticCorporateDebtSecuritiesMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-06-300000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignCorporateDebtSecuritiesMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ForeignCorporateDebtSecuritiesMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignCorporateDebtSecuritiesMember2022-06-300000064803us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300000064803us-gaap:FairValueInputsLevel2Memberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000064803us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300000064803us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000064803us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803cvs:OtherAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300000064803us-gaap:FairValueInputsLevel2Membercvs:OtherAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803cvs:OtherAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000064803cvs:OtherAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803us-gaap:RedeemablePreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300000064803us-gaap:FairValueInputsLevel2Memberus-gaap:RedeemablePreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803us-gaap:RedeemablePreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000064803us-gaap:RedeemablePreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel1Member2021-12-310000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DomesticCorporateDebtSecuritiesMember2021-12-310000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DomesticCorporateDebtSecuritiesMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DomesticCorporateDebtSecuritiesMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DomesticCorporateDebtSecuritiesMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignCorporateDebtSecuritiesMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ForeignCorporateDebtSecuritiesMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignCorporateDebtSecuritiesMember2021-12-310000064803us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000064803us-gaap:FairValueInputsLevel2Memberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000064803us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000064803us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000064803us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803cvs:OtherAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000064803us-gaap:FairValueInputsLevel2Membercvs:OtherAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803cvs:OtherAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000064803cvs:OtherAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803us-gaap:RedeemablePreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000064803us-gaap:FairValueInputsLevel2Memberus-gaap:RedeemablePreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803us-gaap:RedeemablePreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000064803us-gaap:RedeemablePreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2022-06-300000064803us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300000064803us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2022-06-300000064803us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000064803us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2022-06-300000064803us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2021-12-310000064803us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000064803us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2021-12-310000064803us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000064803us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsNonrecurringMember2021-12-310000064803us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300000064803us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000064803us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000064803us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000064803us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803us-gaap:DebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300000064803us-gaap:FairValueInputsLevel2Memberus-gaap:DebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803us-gaap:DebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000064803us-gaap:DebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803us-gaap:DebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000064803us-gaap:FairValueInputsLevel2Memberus-gaap:DebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803us-gaap:DebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000064803us-gaap:DebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-06-300000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Membercvs:CommonAndCollectiveTrustsMember2022-06-300000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembercvs:CommonAndCollectiveTrustsMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Membercvs:CommonAndCollectiveTrustsMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMembercvs:CommonAndCollectiveTrustsMember2022-06-300000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Membercvs:CommonAndCollectiveTrustsMember2021-12-310000064803us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembercvs:CommonAndCollectiveTrustsMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Membercvs:CommonAndCollectiveTrustsMember2021-12-310000064803us-gaap:FairValueMeasurementsRecurringMembercvs:CommonAndCollectiveTrustsMember2021-12-310000064803cvs:OtherReceivablesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000064803cvs:OtherReceivablesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000064803us-gaap:HealthInsuranceProductLineMember2021-12-310000064803us-gaap:HealthInsuranceProductLineMember2020-12-310000064803us-gaap:HealthInsuranceProductLineMember2022-01-012022-06-300000064803us-gaap:HealthInsuranceProductLineMember2021-01-012021-06-300000064803us-gaap:HealthInsuranceProductLineMember2022-06-300000064803us-gaap:HealthInsuranceProductLineMember2021-06-300000064803cvs:HealthCareBenefitsSegmentMember2021-01-012021-06-300000064803cvs:CorporateOtherMember2022-01-012022-06-300000064803cvs:CorporateOtherMember2021-01-012021-06-300000064803cvs:SeniorNotes3.5DueJuly2022Memberus-gaap:SeniorNotesMember2022-06-30xbrli:pure0000064803cvs:SeniorNotes3.5DueJuly2022Memberus-gaap:SeniorNotesMember2021-12-310000064803us-gaap:SeniorNotesMembercvs:SeniorNotes2.75DueNovember2022Member2022-06-300000064803us-gaap:SeniorNotesMembercvs:SeniorNotes2.75DueNovember2022Member2021-12-310000064803cvs:SeniorNotes2.75DueDecember2022Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes2.75DueDecember2022Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes4.75DueDecember2022Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes4.75DueDecember2022Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes2.8DueJune2023Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes2.8DueJune2023Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes4DueDecember2023Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes4DueDecember2023Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes3.375DueAugust2024Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes3.375DueAugust2024Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes2.625DueAugust2024Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes2.625DueAugust2024Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes3.5DueNovember2024Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes3.5DueNovember2024Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes5DueDecember2024Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes5DueDecember2024Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes4.1DueMarch2025Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes4.1DueMarch2025Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes3.875DueJuly2025Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes3.875DueJuly2025Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes2.875DueJune2026Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes2.875DueJune2026Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes3DueAugust2026Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes3DueAugust2026Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes3.625DueApril2027Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes3.625DueApril2027Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes6.25DueJune2027Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes6.25DueJune2027Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes13DueAugust2027Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes13DueAugust2027Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes4.3DueMarch2028Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes4.3DueMarch2028Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes3.25DueAugust2029Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes3.25DueAugust2029Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes3.75DueApril2030Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes3.75DueApril2030Memberus-gaap:SeniorNotesMember2021-12-310000064803us-gaap:SeniorNotesMembercvs:SeniorNotes175DueAugust2030Member2022-06-300000064803us-gaap:SeniorNotesMembercvs:SeniorNotes175DueAugust2030Member2021-12-310000064803cvs:SeniorNotes1875DueFebruary2031Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes1875DueFebruary2031Memberus-gaap:SeniorNotesMember2021-12-310000064803us-gaap:SeniorNotesMembercvs:SeniorNotes2125PercentDueSeptember2031Member2022-06-300000064803us-gaap:SeniorNotesMembercvs:SeniorNotes2125PercentDueSeptember2031Member2021-12-310000064803us-gaap:SeniorNotesMembercvs:SeniorNotes4.875DueJuly2035Member2022-06-300000064803us-gaap:SeniorNotesMembercvs:SeniorNotes4.875DueJuly2035Member2021-12-310000064803cvs:SeniorNotes6.625DueJune2036Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes6.625DueJune2036Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes6.75DueDecember2037Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes6.75DueDecember2037Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes4.78DueMarch2038Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes4.78DueMarch2038Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes6.125DueSeptember2039Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes6.125DueSeptember2039Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes4.125DueApril2040Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes4.125DueApril2040Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes27DueAugust2040Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes27DueAugust2040Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes5.75DueMay2041Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes5.75DueMay2041Memberus-gaap:SeniorNotesMember2021-12-310000064803us-gaap:SeniorNotesMembercvs:SeniorNotes4.5DueMay2042Member2022-06-300000064803us-gaap:SeniorNotesMembercvs:SeniorNotes4.5DueMay2042Member2021-12-310000064803us-gaap:SeniorNotesMembercvs:SeniorNotes4.125DueNovember2042Member2022-06-300000064803us-gaap:SeniorNotesMembercvs:SeniorNotes4.125DueNovember2042Member2021-12-310000064803us-gaap:SeniorNotesMembercvs:SeniorNotes5.3DueDecember2043Member2022-06-300000064803us-gaap:SeniorNotesMembercvs:SeniorNotes5.3DueDecember2043Member2021-12-310000064803us-gaap:SeniorNotesMembercvs:SeniorNotes4.75DueMarch2044Member2022-06-300000064803us-gaap:SeniorNotesMembercvs:SeniorNotes4.75DueMarch2044Member2021-12-310000064803cvs:SeniorNotes5.125DueJuly2045Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes5.125DueJuly2045Memberus-gaap:SeniorNotesMember2021-12-310000064803us-gaap:SeniorNotesMembercvs:SeniorNotes3.875DueAugust2047Member2022-06-300000064803us-gaap:SeniorNotesMembercvs:SeniorNotes3.875DueAugust2047Member2021-12-310000064803cvs:SeniorNotes5.05DueMarch2048Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes5.05DueMarch2048Memberus-gaap:SeniorNotesMember2021-12-310000064803cvs:SeniorNotes4.25DueApril2050Memberus-gaap:SeniorNotesMember2022-06-300000064803cvs:SeniorNotes4.25DueApril2050Memberus-gaap:SeniorNotesMember2021-12-310000064803us-gaap:OtherDebtSecuritiesMember2022-06-300000064803us-gaap:OtherDebtSecuritiesMember2021-12-310000064803cvs:SeniorNotes3.5DueJuly2022Memberus-gaap:SeniorNotesMember2022-05-310000064803cvs:SeniorNotes3.5DueJuly2022Memberus-gaap:SeniorNotesMember2022-05-012022-05-310000064803srt:ScenarioForecastMemberus-gaap:SubsequentEventMemberus-gaap:SeniorNotesMembercvs:SeniorNotes2.75DueNovember2022Member2022-08-150000064803srt:ScenarioForecastMemberus-gaap:SubsequentEventMemberus-gaap:SeniorNotesMembercvs:SeniorNotes2.75DueNovember2022Member2022-08-152022-08-150000064803srt:ScenarioForecastMemberus-gaap:SubsequentEventMembercvs:SeniorNotes2.75DueDecember2022Memberus-gaap:SeniorNotesMember2022-09-010000064803srt:ScenarioForecastMemberus-gaap:SubsequentEventMembercvs:SeniorNotes4.75DueDecember2022Memberus-gaap:SeniorNotesMember2022-09-010000064803srt:ScenarioForecastMemberus-gaap:SubsequentEventMembercvs:SeniorNotes2.75DueDecember2022Memberus-gaap:SeniorNotesMember2022-09-012022-09-010000064803srt:ScenarioForecastMemberus-gaap:SubsequentEventMembercvs:SeniorNotes4.75DueDecember2022Memberus-gaap:SeniorNotesMember2022-09-012022-09-010000064803cvs:A2021RepurchaseProgramMember2021-12-090000064803cvs:A2021RepurchaseProgramMember2022-06-300000064803cvs:A2021RepurchaseProgramMember2022-01-012022-06-300000064803cvs:A2021AcceleratedRepurchaseProgramMembercvs:BarclaysBankMember2022-01-040000064803cvs:A2021AcceleratedRepurchaseProgramMembercvs:BarclaysBankMember2022-01-042022-01-040000064803cvs:A2021AcceleratedRepurchaseProgramMembercvs:BarclaysBankMemberus-gaap:ForwardContractsMember2022-01-040000064803cvs:A2021AcceleratedRepurchaseProgramMembercvs:BarclaysBankMember2022-02-280000064803us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-03-310000064803us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2021-03-310000064803us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2021-12-310000064803us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2020-12-310000064803us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-04-012022-06-300000064803us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2021-04-012021-06-300000064803us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-01-012022-06-300000064803us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2021-01-012021-06-300000064803us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-06-300000064803us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2021-06-300000064803us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-03-310000064803us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-03-310000064803us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-12-310000064803us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-12-310000064803us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-04-012022-06-300000064803us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-04-012021-06-300000064803us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-01-012022-06-300000064803us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-01-012021-06-300000064803us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-06-300000064803us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-06-300000064803us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-03-310000064803us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-03-310000064803us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-12-310000064803us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2020-12-310000064803us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-04-012022-06-300000064803us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-04-012021-06-300000064803us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-01-012022-06-300000064803us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-01-012021-06-300000064803us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-06-300000064803us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-06-300000064803us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-03-310000064803us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2021-03-310000064803us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2021-12-310000064803us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2020-12-310000064803us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-04-012022-06-300000064803us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2021-04-012021-06-300000064803us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-01-012022-06-300000064803us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2021-01-012021-06-300000064803us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-06-300000064803us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2021-06-300000064803us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-03-310000064803us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-03-310000064803us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-12-310000064803us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2020-12-310000064803us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-06-300000064803us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-06-300000064803cvs:StockOptionsAndStockAppreciationRightsMember2022-04-012022-06-300000064803cvs:StockOptionsAndStockAppreciationRightsMember2022-01-012022-06-300000064803cvs:StockOptionsAndStockAppreciationRightsMember2021-04-012021-06-300000064803cvs:StockOptionsAndStockAppreciationRightsMember2021-01-012021-06-300000064803cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember2022-04-012022-06-300000064803cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember2021-04-012021-06-300000064803cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember2022-01-012022-06-300000064803cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember2021-01-012021-06-30cvs:lease0000064803cvs:StateOfFloridaSettlementMember2022-03-012022-03-310000064803cvs:StateOfFloridaSettlementMember2022-03-3100000648032012-01-012012-12-310000064803cvs:RadcliffeAndFlaimVAetnaIncEtAlMemberus-gaap:PendingLitigationMember2020-09-30cvs:claim0000064803us-gaap:IntersegmentEliminationMembercvs:HealthCareBenefitsSegmentMember2022-04-012022-06-300000064803us-gaap:IntersegmentEliminationMembercvs:PharmacyServicesSegmentMember2022-04-012022-06-300000064803us-gaap:IntersegmentEliminationMembercvs:RetailLongTermCareSegmentMember2022-04-012022-06-300000064803cvs:HealthCareBenefitsSegmentMember2022-04-012022-06-300000064803cvs:PharmacyServicesSegmentMember2022-04-012022-06-300000064803cvs:RetailLongTermCareSegmentMember2022-04-012022-06-300000064803us-gaap:IntersegmentEliminationMembercvs:HealthCareBenefitsSegmentMember2021-04-012021-06-300000064803us-gaap:IntersegmentEliminationMembercvs:PharmacyServicesSegmentMember2021-04-012021-06-300000064803us-gaap:IntersegmentEliminationMembercvs:RetailLongTermCareSegmentMember2021-04-012021-06-300000064803cvs:HealthCareBenefitsSegmentMember2021-04-012021-06-300000064803cvs:PharmacyServicesSegmentMember2021-04-012021-06-300000064803cvs:RetailLongTermCareSegmentMember2021-04-012021-06-300000064803us-gaap:IntersegmentEliminationMembercvs:HealthCareBenefitsSegmentMember2022-01-012022-06-300000064803us-gaap:IntersegmentEliminationMembercvs:PharmacyServicesSegmentMember2022-01-012022-06-300000064803us-gaap:IntersegmentEliminationMembercvs:RetailLongTermCareSegmentMember2022-01-012022-06-300000064803cvs:PharmacyServicesSegmentMember2022-01-012022-06-300000064803cvs:RetailLongTermCareSegmentMember2022-01-012022-06-300000064803us-gaap:IntersegmentEliminationMembercvs:HealthCareBenefitsSegmentMember2021-01-012021-06-300000064803us-gaap:IntersegmentEliminationMembercvs:PharmacyServicesSegmentMember2021-01-012021-06-300000064803us-gaap:IntersegmentEliminationMembercvs:RetailLongTermCareSegmentMember2021-01-012021-06-300000064803cvs:PharmacyServicesSegmentMember2021-01-012021-06-300000064803cvs:RetailLongTermCareSegmentMember2021-01-012021-06-300000064803cvs:StateOfFloridaSettlementMember2022-01-012022-06-300000064803cvs:StateOfFloridaSettlementMember2022-06-3000000648032021-06-012021-06-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2022
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________ to_________
Commission File Number: 001-01011
CVS HEALTH CORPORATION
(Exact name of registrant as specified in its charter)
| | | | | | | | |
Delaware | | 05-0494040 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| | | | | | | | | | | | | | | | | | | | |
| One CVS Drive, | Woonsocket, | Rhode Island | | 02895 |
(Address of principal executive offices) | | (Zip Code) |
| | | | |
Registrant’s telephone number, including area code: | | (401) | 765-1500 |
Former name, former address and former fiscal year, if changed since last report: | N/A |
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common Stock, par value $0.01 per share | CVS | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☑ Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☑ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | |
Large accelerated filer | ☑ | Accelerated filer | ☐ |
Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☑ No
As of July 27, 2022, the registrant had 1,312,828,807 shares of common stock issued and outstanding.
| | | | | | | | |
TABLE OF CONTENTS | |
| | Page |
Part I | Financial Information | |
| | |
Item 1. | | |
Item 2. | | |
Item 3. | | |
Item 4. | | |
| | |
Part II | Other Information | |
| | |
Item 1. | | |
Item 1A. | | |
Item 2. | | |
Item 3 | | |
Item 4. | | |
Item 5. | | |
Item 6. | | |
| | |
| |
Part I.Financial Information
Item 1.Financial Statements
Index to Condensed Consolidated Financial Statements
| | | | | |
| Page |
Condensed Consolidated Statements of Operations (Unaudited) for the three and six months ended June 30, 2022 and 2021 | |
| |
Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three and six months ended June 30, 2022 and 2021 | |
| |
Condensed Consolidated Balance Sheets (Unaudited) as of June 30, 2022 and December 31, 2021 | |
| |
Condensed Consolidated Statements of Cash Flows (Unaudited) for the six months ended June 30, 2022 and 2021 | |
| |
Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) for the three months ended June 30, 2022 and 2021 and the three months ended March 31, 2022 and 2021 | |
| |
Notes to Condensed Consolidated Financial Statements (Unaudited) | |
| |
Report of Independent Registered Public Accounting Firm | |
CVS Health Corporation
Condensed Consolidated Statements of Operations
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended June 30, | | Six Months Ended June 30, |
In millions, except per share amounts | 2022 | | 2021 | | 2022 | | 2021 |
Revenues: | | | | | | | |
Products | $ | 56,794 | | | $ | 50,525 | | | $ | 109,316 | | | $ | 97,912 | |
Premiums | 21,260 | | | 18,983 | | | 42,891 | | | 37,943 | |
Services | 2,436 | | | 2,819 | | | 4,941 | | | 5,272 | |
Net investment income | 146 | | | 289 | | | 314 | | | 586 | |
Total revenues | 80,636 | | | 72,616 | | | 157,462 | | | 141,713 | |
Operating costs: | | | | | | | |
Cost of products sold | 49,290 | | | 43,520 | | | 94,799 | | | 84,414 | |
Benefit costs | 17,606 | | | 15,901 | | | 35,557 | | | 31,605 | |
| | | | | | | |
Operating expenses | 9,171 | | | 8,869 | | | 19,047 | | | 17,791 | |
Total operating costs | 76,067 | | | 68,290 | | | 149,403 | | | 133,810 | |
Operating income | 4,569 | | | 4,326 | | | 8,059 | | | 7,903 | |
Interest expense | 583 | | | 636 | | | 1,169 | | | 1,293 | |
| | | | | | | |
Other income | (43) | | | (45) | | | (85) | | | (95) | |
Income before income tax provision | 4,029 | | | 3,735 | | | 6,975 | | | 6,705 | |
Income tax provision | 1,068 | | | 944 | | | 1,701 | | | 1,690 | |
| | | | | | | |
| | | | | | | |
Net income | 2,961 | | | 2,791 | | | 5,274 | | | 5,015 | |
Net income attributable to noncontrolling interests | (10) | | | (8) | | | (11) | | | (9) | |
Net income attributable to CVS Health | $ | 2,951 | | | $ | 2,783 | | | $ | 5,263 | | | $ | 5,006 | |
| | | | | | | |
Net income per share attributable to CVS Health: | | | | | | | |
Basic | $ | 2.25 | | | $ | 2.11 | | | $ | 4.01 | | | $ | 3.80 | |
Diluted | $ | 2.23 | | | $ | 2.10 | | | $ | 3.97 | | | $ | 3.78 | |
Weighted average shares outstanding: | | | | | | | |
Basic | 1,313 | | | 1,319 | | | 1,312 | | | 1,316 | |
Diluted | 1,321 | | | 1,327 | | | 1,325 | | | 1,325 | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Dividends declared per share | $ | 0.55 | | | $ | 0.50 | | | $ | 1.10 | | | $ | 1.00 | |
See accompanying notes to condensed consolidated financial statements (unaudited).
CVS Health Corporation
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended June 30, | | Six Months Ended June 30, |
In millions | 2022 | | 2021 | | 2022 | | 2021 |
Net income | $ | 2,961 | | | $ | 2,791 | | | $ | 5,274 | | | $ | 5,015 | |
Other comprehensive income (loss), net of tax: | | | | | | | |
Net unrealized investment gains (losses) | (813) | | | 149 | | | (1,968) | | | (237) | |
Foreign currency translation adjustments | (1) | | | 1 | | | 2 | | | (1) | |
Net cash flow hedges | 15 | | | (3) | | | 12 | | | (7) | |
Pension and other postretirement benefits | 1 | | | 1 | | | 1 | | | 1 | |
Other comprehensive income (loss) | (798) | | | 148 | | | (1,953) | | | (244) | |
Comprehensive income | 2,163 | | | 2,939 | | | 3,321 | | | 4,771 | |
Comprehensive income attributable to noncontrolling interests | (10) | | | (8) | | | (11) | | | (9) | |
Comprehensive income attributable to CVS Health | $ | 2,153 | | | $ | 2,931 | | | $ | 3,310 | | | $ | 4,762 | |
See accompanying notes to condensed consolidated financial statements (unaudited).
CVS Health Corporation
Condensed Consolidated Balance Sheets
(Unaudited)
| | | | | | | | | | | |
In millions, except per share amounts | June 30, 2022 | | December 31, 2021 |
Assets: | | | |
Cash and cash equivalents | $ | 12,116 | | | $ | 9,408 | |
Investments | 2,877 | | | 3,117 | |
Accounts receivable, net | 27,233 | | | 24,431 | |
Inventories | 17,375 | | | 17,760 | |
Other current assets | 2,541 | | | 5,292 | |
Total current assets | 62,142 | | | 60,008 | |
Long-term investments | 21,124 | | | 23,025 | |
Property and equipment, net | 12,764 | | | 12,896 | |
Operating lease right-of-use assets | 18,562 | | | 19,122 | |
Goodwill | 78,560 | | | 79,121 | |
Intangible assets, net | 28,135 | | | 29,026 | |
Separate accounts assets | 4,140 | | | 5,087 | |
Other assets | 4,852 | | | 4,714 | |
Total assets | $ | 230,279 | | | $ | 232,999 | |
| | | |
Liabilities: | | | |
Accounts payable | $ | 13,238 | | | $ | 12,544 | |
Pharmacy claims and discounts payable | 18,393 | | | 17,330 | |
Health care costs payable | 10,400 | | | 8,808 | |
Policyholders’ funds | 1,628 | | | 4,301 | |
Accrued expenses | 17,728 | | | 17,670 | |
Other insurance liabilities | 1,197 | | | 1,303 | |
Current portion of operating lease liabilities | 1,854 | | | 1,646 | |
| | | |
Current portion of long-term debt | 4,019 | | | 4,205 | |
Total current liabilities | 68,457 | | | 67,807 | |
Long-term operating lease liabilities | 17,502 | | | 18,177 | |
Long-term debt | 50,797 | | | 51,971 | |
Deferred income taxes | 5,450 | | | 6,270 | |
Separate accounts liabilities | 4,140 | | | 5,087 | |
Other long-term insurance liabilities | 6,287 | | | 6,402 | |
Other long-term liabilities | 2,140 | | | 1,904 | |
Total liabilities | 154,773 | | | 157,618 | |
| | | |
Shareholders’ equity: | | | |
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | — | | | — | |
Common stock, par value $0.01: 3,200 shares authorized; 1,755 shares issued and 1,312 shares outstanding at June 30, 2022 and 1,744 shares issued and 1,322 shares outstanding at December 31, 2021 and capital surplus | 47,874 | | | 47,377 | |
Treasury stock, at cost: 443 shares at June 30, 2022 and 422 shares at December 31, 2021 | (30,412) | | | (28,173) | |
Retained earnings | 58,710 | | | 54,906 | |
Accumulated other comprehensive income (loss) | (988) | | | 965 | |
Total CVS Health shareholders’ equity | 75,184 | | | 75,075 | |
Noncontrolling interests | 322 | | | 306 | |
Total shareholders’ equity | 75,506 | | | 75,381 | |
Total liabilities and shareholders’ equity | $ | 230,279 | | | $ | 232,999 | |
See accompanying notes to condensed consolidated financial statements (unaudited).
CVS Health Corporation
Condensed Consolidated Statements of Cash Flows
(Unaudited)
| | | | | | | | | | | |
| Six Months Ended June 30, |
In millions | 2022 | | 2021 |
Cash flows from operating activities: | | | |
Cash receipts from customers | $ | 151,769 | | | $ | 136,621 | |
Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (90,887) | | | (79,316) | |
Insurance benefits paid | (33,920) | | | (31,245) | |
Cash paid to other suppliers and employees | (15,119) | | | (14,900) | |
Interest and investment income received | 200 | | | 394 | |
Interest paid | (1,150) | | | (1,263) | |
Income taxes paid | (1,887) | | | (1,552) | |
Net cash provided by operating activities | 9,006 | | | 8,739 | |
| | | |
Cash flows from investing activities: | | | |
Proceeds from sales and maturities of investments | 4,360 | | | 3,947 | |
Purchases of investments | (5,010) | | | (5,570) | |
Purchases of property and equipment | (1,459) | | | (1,315) | |
Acquisitions (net of cash acquired) | (125) | | | (108) | |
Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,807) | (1,943) | | | — | |
Other | 54 | | | 72 | |
Net cash used in investing activities | (4,123) | | | (2,974) | |
| | | |
Cash flows from financing activities: | | | |
| | | |
| | | |
Repayments of long-term debt | (1,529) | | | (5,423) | |
Repurchase of common stock | (2,000) | | | — | |
| | | |
Dividends paid | (1,462) | | | (1,306) | |
Proceeds from exercise of stock options | 348 | | | 330 | |
Payments for taxes related to net share settlement of equity awards | (329) | | | (159) | |
Other | (139) | | | 46 | |
Net cash used in financing activities | (5,111) | | | (6,512) | |
Net decrease in cash, cash equivalents and restricted cash | (228) | | | (747) | |
Cash, cash equivalents and restricted cash at the beginning of the period | 12,691 | | | 11,043 | |
Cash, cash equivalents and restricted cash at the end of the period | $ | 12,463 | | | $ | 10,296 | |
CVS Health Corporation
Condensed Consolidated Statements of Cash Flows
(Unaudited)
| | | | | | | | | | | |
| Six Months Ended June 30, |
In millions | 2022 | | 2021 |
Reconciliation of net income to net cash provided by operating activities: | | | |
Net income | $ | 5,274 | | | $ | 5,015 | |
Adjustments required to reconcile net income to net cash provided by operating activities: | | | |
Depreciation and amortization | 2,142 | | | 2,263 | |
| | | |
Stock-based compensation | 236 | | | 232 | |
Gain on sale of subsidiary | (225) | | | — | |
| | | |
Deferred income taxes and other noncash items | (281) | | | (370) | |
Change in operating assets and liabilities, net of effects from acquisitions: | | | |
Accounts receivable, net | (2,687) | | | (2,384) | |
Inventories | 469 | | | 1,517 | |
Other assets | (325) | | | (219) | |
Accounts payable and pharmacy claims and discounts payable | 2,033 | | | 1,702 | |
Health care costs payable and other insurance liabilities | 1,467 | | | 104 | |
Other liabilities | 903 | | | 879 | |
Net cash provided by operating activities | $ | 9,006 | | | $ | 8,739 | |
See accompanying notes to condensed consolidated financial statements (unaudited).
CVS Health Corporation
Condensed Consolidated Statements of Shareholders’ Equity
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Attributable to CVS Health | | |
| Number of shares outstanding | | Common Stock and Capital Surplus (2) | Treasury Stock (1) | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Total CVS Health Shareholders’ Equity | Noncontrolling Interests | Total Shareholders’ Equity |
| |
| Common Shares | Treasury Shares (1) | |
In millions | |
Balance at December 31, 2021 | 1,744 | | (422) | | | $ | 47,377 | | $ | (28,173) | | $ | 54,906 | | $ | 965 | | $ | 75,075 | | $ | 306 | | $ | 75,381 | |
Net income | — | | — | | | — | | — | | 2,312 | | — | | 2,312 | | 1 | | 2,313 | |
Other comprehensive loss | — | | — | | | — | | — | | — | | (1,155) | | (1,155) | | — | | (1,155) | |
Stock option activity, stock awards and other | 3 | | — | | | 300 | | — | | — | | — | | 300 | | — | | 300 | |
Purchase of treasury shares, net of ESPP issuances | — | | (19) | | | — | | (1,972) | | — | | — | | (1,972) | | — | | (1,972) | |
Common stock dividends | — | | — | | | — | | — | | (730) | | — | | (730) | | — | | (730) | |
Other increases in noncontrolling interests | — | | — | | | — | | — | | — | | — | | — | | 3 | | 3 | |
Balance at March 31, 2022 | 1,747 | | (441) | | | 47,677 | | (30,145) | | 56,488 | | (190) | | 73,830 | | 310 | | 74,140 | |
Net income | — | | — | | | — | | — | | 2,951 | | — | | 2,951 | | 10 | | 2,961 | |
Other comprehensive loss (Note 8) | — | | — | | | — | | — | | — | | (798) | | (798) | | — | | (798) | |
Stock option activity, stock awards and other | 8 | | — | | | 197 | | — | | — | | — | | 197 | | — | | 197 | |
Purchase of treasury shares, net of ESPP issuances | — | | (2) | | | — | | (267) | | — | | — | | (267) | | — | | (267) | |
Common stock dividends | — | | — | | | — | | — | | (729) | | — | | (729) | | — | | (729) | |
Other increases in noncontrolling interests | — | | — | | | — | | — | | — | | — | | — | | 2 | | 2 | |
Balance at June 30, 2022 | 1,755 | | (443) | | | $ | 47,874 | | $ | (30,412) | | $ | 58,710 | | $ | (988) | | $ | 75,184 | | $ | 322 | | $ | 75,506 | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
_____________________________________________
(1)Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of June 30, 2022, March 31, 2022 and December 31, 2021.
(2)Common stock and capital surplus includes the par value of common stock of $18 million as of June 30, 2022 and $17 million as of March 31, 2022 and December 31, 2021.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Attributable to CVS Health | | |
| Number of shares outstanding | | Common Stock and Capital Surplus (2) | Treasury Stock (1) | Retained Earnings | Accumulated Other Comprehensive Income | Total CVS Health Shareholders’ Equity | Noncontrolling Interests | Total Shareholders’ Equity |
| |
| Common Shares | Treasury Shares (1) | |
In millions | |
Balance at December 31, 2020 | 1,733 | | (423) | | | $ | 46,513 | | $ | (28,178) | | $ | 49,640 | | $ | 1,414 | | $ | 69,389 | | $ | 312 | | $ | 69,701 | |
Net income | — | | — | | | — | | — | | 2,223 | | — | | 2,223 | | 1 | | 2,224 | |
Other comprehensive loss | — | | — | | | — | | — | | — | | (392) | | (392) | | — | | (392) | |
Stock option activity, stock awards and other | 2 | | — | | | 214 | | — | | — | | — | | 214 | | — | | 214 | |
ESPP issuances, net of purchase of treasury shares | — | | 1 | | | — | | 76 | | — | | — | | 76 | | — | | 76 | |
Common stock dividends | — | | — | | | — | | — | | (660) | | — | | (660) | | — | | (660) | |
Other increases in noncontrolling interests | — | | — | | | — | | — | | — | | — | | — | | 1 | | 1 | |
Balance at March 31, 2021 | 1,735 | | (422) | | | 46,727 | | (28,102) | | 51,203 | | 1,022 | | 70,850 | | 314 | | 71,164 | |
Net income | — | | — | | | — | | — | | 2,783 | | — | | 2,783 | | 8 | | 2,791 | |
Other comprehensive income (Note 8) | — | | — | | | — | | — | | — | | 148 | | 148 | | — | | 148 | |
Stock option activity, stock awards and other | 7 | | — | | | 268 | | — | | — | | — | | 268 | | — | | 268 | |
Purchase of treasury shares, net of ESPP issuances | — | | (2) | | | — | | (150) | | — | | — | | (150) | | — | | (150) | |
Common stock dividends | — | | — | | | — | | — | | (655) | | — | | (655) | | — | | (655) | |
Other decreases in noncontrolling interests | — | | — | | | — | | — | | — | | — | | — | | (1) | | (1) | |
Balance at June 30, 2021 | 1,742 | | (424) | | | $ | 46,995 | | $ | (28,252) | | $ | 53,331 | | $ | 1,170 | | $ | 73,244 | | $ | 321 | | $ | 73,565 | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
_____________________________________________
(1)Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of June 30, 2021, March 31, 2021 and December 31, 2020.
(2)Common stock and capital surplus includes the par value of common stock of $